Back
Invesco Bloomberg Analyst Rating Improvers ETF Vs. Tyra Biosciences, Inc. Industry Stock Comparison
Buy
63
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
Last Price:
$76.72
Seasonality Move:
5.42%
Buy
71
TYRA
Tyra Biosciences, Inc.
Last Price:
$29.56
Seasonality Move:
24.67%
Buy
63
Invesco Bloomberg Analyst Rating Improvers ETF (UPGD)
is a Buy
Is Invesco Bloomberg Analyst Rating Improvers ETF a Buy, Sell or Hold?
-
The current Invesco Bloomberg Analyst Rating Improvers ETF [UPGD] share price is $76.19. The Score for UPGD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
UPGD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Tyra Biosciences, Inc. (TYRA)
is a Buy
Is Tyra Biosciences, Inc. a Buy, Sell or Hold?
-
The current Tyra Biosciences, Inc. [TYRA] share price is $30.35. The Score for TYRA is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
TYRA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UPGD Stock Price Chart
What is Invesco Bloomberg Analyst Rating Improvers ETF's stock price today?
-
The Invesco Bloomberg Analyst Rating Improvers ETF share price today is $76.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPGD is experiencing buying pressure, which is a positive indicator for future bullish movement.
TYRA Stock Price Chart
What is Tyra Biosciences, Inc.'s stock price today?
-
The Tyra Biosciences, Inc. share price today is $30.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TYRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
UPGD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 19.1 | Buy |
| Relative Strength Index (14 RSI): | 59.37 | Buy |
| Chaikin Money Flow: | 746 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (74.59 - 75.93) | Buy |
| Bollinger Bands (100): | (73.37 - 75.51) | Buy |
TYRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.17 | Buy |
| Relative Strength Index (14 RSI): | 81.45 | Buy |
| Chaikin Money Flow: | 539963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.15 - 27.01) | Buy |
| Bollinger Bands (100): | (11.78 - 22.14) | Buy |
UPGD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.03 | Buy |
| 20-day SMA: | 75.39 | Buy |
| 50-day SMA: | 74.31 | Buy |
| 200-day SMA: | 72.22 | Buy |
| 8-day EMA: | 72.42 | Buy |
| 20-day EMA: | 54.75 | Buy |
| 50-day EMA: | 30.51 | Buy |
| 200-day EMA: | 9.17 | Buy |
TYRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.15 | Buy |
| 20-day SMA: | 25.21 | Buy |
| 50-day SMA: | 20.95 | Buy |
| 200-day SMA: | 13.42 | Buy |
| 8-day EMA: | 27.65 | Buy |
| 20-day EMA: | 25.53 | Buy |
| 50-day EMA: | 21.92 | Buy |
| 200-day EMA: | 16.1 | Buy |
Invesco Bloomberg Analyst Rating Improvers ETF Earnings Growth & UPGD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tyra Biosciences, Inc. Earnings Growth & TYRA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.10 per share.
Invesco Bloomberg Analyst Rating Improvers ETF Technical Analysis
| Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tyra Biosciences, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||